Activation-induced changes in peptides presented by T cells.

被引：0
|
作者：
Frumento, G [1 ]
Rubartelli, A [1 ]
Ferrara, GB [1 ]
机构：
[1] IST,CBA,IMMUNOGENET LAB,GENOA,ITALY
来源：
HUMAN IMMUNOLOGY | 1996年 / 47卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：P91 / P91
页数：1
相关论文
共 50 条
  • [1] Estrogen prevents activation-induced apoptosis by downregulation of Fas ligand expression in T cells.
    Min, SY
    Cho, ML
    Choi, JJ
    Park, KS
    Yoon, CH
    Kang, HJ
    Min, DJ
    Kim, WU
    Min, JK
    Hong, YS
    Park, SH
    Hwang, SY
    Lee, JL
    Cho, CS
    Kim, HY
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S204 - S204
  • [2] Activation-induced cell death in T cells
    Green, DR
    Droin, N
    Pinkoski, M
    [J]. IMMUNOLOGICAL REVIEWS, 2003, 193 (01) : 70 - 81
  • [3] Activation-Induced Cell Death in T Cells and Autoimmunity
    Zhang, Jian
    Xu, Xuemei
    Liu, Yong
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2004, 1 (03) : 186 - 192
  • [4] Activation-Induced Cell Death in T Cells and Autoimmunity
    Jian Zhang Xuemei Xu Yong Liu Departments of Orthopedic Surgery and Immunology/Microbiology
    [J]. Cellular & Molecular Immunology, 2004, (03) : 186 - 192
  • [5] Receptors and ligands that mediate activation-induced death of T cells
    Alderson, MR
    Lynch, DH
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 19 (03): : 289 - 300
  • [6] Receptors and ligands that mediate activation-induced death of T cells
    Mark R. Alderson
    David H. Lynch
    [J]. Springer Seminars in Immunopathology, 1998, 19 : 289 - 300
  • [7] Paradoxical responses of autoimmune T cells: Activation-induced anergy?
    Dubey, Shweta
    Wang, James
    Singh, Ram R.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S282 - S282
  • [8] Activation-induced T cell death
    Walczak, H
    Dhein, J
    Peter, ME
    Krammer, PH
    [J]. CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 245 - 245
  • [9] Activation-induced cell death of T cells is prevented by coculture with dendritic cells
    Daniel, PT
    Scholz, C
    Westermann, J
    Daemen, K
    Dorken, B
    Pezzutto, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 77 - 77
  • [10] Imatinib mesylate disrupts cell cycle progression, modifies the nucleoskeleton and suppresses activation-induced transcription in human T cells.
    Dietz, A
    Johnson, WB
    Knutson, GJ
    Bulur, PA
    Schulenberg, B
    Beechem, JM
    Prendergast, FG
    Vuk-Pavlovic, S
    [J]. BLOOD, 2004, 104 (11) : 796A - 796A
12345